Publicaciones en las que colabora con ESTHER CULEBRAS LÓPEZ (11)

2024

  1. Cell immunity to SARS-CoV-2 after natural infection and/or different vaccination regimens

    Frontiers in Cellular and Infection Microbiology, Vol. 14

2023

  1. Evolution of antibody titers after two doses of mRNA Pfizer-BioNTech vaccine and effect of the third dose in nursing home residents

    PLoS ONE, Vol. 18, Núm. 3 March

  2. High performance of the automated ADVIA Centaur Systems SARS-CoV-2 Antigen Assay in nasopharyngeal samples with high viral load

    International Microbiology, Vol. 26, Núm. 3, pp. 471-474

  3. Role of Hologic® Panther AptimaTM SARS-CoV-2 assay in the detection of SARS-CoV-2: screening or diagnostic technique?

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 36, Núm. 5, pp. 516-518

2022

  1. Analysis of Adverse Effects of COVID-19 Vaccines in Spain following Booster Dose

    Vaccines, Vol. 10, Núm. 9

  2. Evaluation of two immunocromatographic tests for the detection of antibodies against SARS-CoV-2

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 6, pp. 538-543

  3. Negative effect of the second dose of the BNT162b2 vaccine in a significant percentage of individuals with previous COVID infection

    International Journal of Infectious Diseases, Vol. 114, pp. 85-87

  4. Usefulness of SARS-CoV-2 antigen test sample as input for SARS-CoV-2 RT-PCR analysis

    Journal of Medical Virology, Vol. 94, Núm. 4, pp. 1693-1695

2021

  1. Comparative study of different SARS-CoV-2 diagnostic techniques

    Journal of Virological Methods, Vol. 298

  2. Serological tests in the detection of SARS-CoV-2 antibodies

    Diagnostics, Vol. 11, Núm. 4

  3. Utilidad de MALDI-TOF y REP-PCR frente a PFGE para el estudio epidemiológico de Acinetobacter baumannii

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 34, Núm. 3, pp. 207-213